At Enzo, we understand that developing a drug, whether it is a new chemical entity, biotherapeutic, or genetic/cellular therapy, requires a significant investment of resources. Every step must be characterized and optimized to produce a quality product from early discovery to production. Contamination monitoring, product integrity, maximizing yield are at the forefront of bioprocessing needs, and our portfolio of bioprocess products can help you achieve your goals. Our highly sensitive ELISAs for contaminants, such as host cell proteins and protein A, are cost-effective solutions for QC analysis during the bioprocess. With over 45 years of experience, partnering with Enzo means solutions you can depend on. We are SCIENTISTS ENABLING HEALTHCARE™.